Community Health Trust (CHCT) Q3 2026 Earnings Call Transcript

Community Healthcare Trust reported Q3 2026 revenue of $32.4 million, up 4.4% year over year, and FFO of $15.0 million ($0.54 per diluted share), up 10.4%; AFFO rose 6.1% to $16.0 million. Leased occupancy improved to 90.1% from 89.8% in Q2, while the company has four properties under purchase agreements totaling $99 million at expected returns of 9.1%–9.75% and maintained its $0.33 quarterly dividend. Net leverage declined to 5.8x, but management cited delays and due-diligence issues in the proposed sale of a tenant’s six behavioral hospital operations and is exploring alternative buyers.

Analysis

CHCT’s key opportunity is a potential capital-allocation arbitrage: monetize assets at private-market prices and redeploy into properties management says yield 9%–10%. That only creates durable per-share value if acquisition yields exceed the all-in cost of capital after downtime, transaction costs and any debt or equity funding. Reported disposition gains are not recurring cash flow; they do not, by themselves, establish that the public-market discount will close. Tax-motivated 1031 demand may also be a temporary tailwind to sale pricing.

Near term, the behavioral-hospital transaction is the critical binary. Expired exclusivity gives CHCT alternatives, but prolonged diligence raises the risk of delayed lease certainty or continued exposure to an operator whose rent recovery may not persist. Alternative bidders improve negotiating leverage only if they can fund operations and execute durable leases. Q4 dispositions and the first acquisition closing are catalysts over the next 1–3 months; redevelopment lease commencements are a 2027 NOI catalyst, contingent on completion, licensing and tenant occupancy.

The contrarian risk is that improving FFO overstates the quality of the run rate: AFFO growth is slower, some G&A relief reflects compensation and stock-award timing, and occupancy improvement remains incremental. At 5.8x net leverage, higher rates or acquisition/disposition timing gaps can consume the spread and constrain growth. The dividend appears covered by current AFFO, but coverage is not a substitute for durable tenant cash flow. Over 6–18 months, successful lease-up and accretive recycling could improve earnings quality; failure to resolve the six-hospital situation or convert the pipeline would leave leverage and vacancy more salient than headline growth.

Key Decisions for Investors

• Do not chase the earnings print. Treat CHCT as a watch/conditional long rather than a confirmed rerating: add only after a disposition and replacement acquisition are both closed and the realized, fully funded yield spread is verified.
• Track the behavioral-hospital process into the next update: require a definitive operating-business sale and executed long-term leases before underwriting normalized rent. A further delay, rent interruption, or deterioration in collections falsifies the near-term recovery thesis.
• Monitor occupancy and project conversion through 2027. Two consecutive quarterly occupancy declines from the reported 90.1%, or missed redevelopment lease commencements beyond the stated first-half 2027 window, would weaken the lease-up case and argue against adding.
• Stress-test financing against another rate increase and acquisition delays: rising interest expense, leverage moving back above the reported 5.8x, or acquisitions funded at yields that fail to clear all-in capital costs would undermine per-share accretion.